Search Ontology:
ChEBI
N-[(2S,3S,4R)-1-(alpha-D-galactopyranosyloxy)-3,4-dihydroxynonan-2-yl]hexacosanamide
- Term ID
- CHEBI:495152
- Synonyms
-
- (2S,3S,4R)-1-(alpha-D-galactopyranosyloxy)-2-hexacosanoylamino-3,4-nonanediol
- (2S,3S,4R)-1-O-(alpha-D-galactosyl)-2-hexacosanoylamino-1,3,4-nonanetriol
- (2S,3S,4R)-2-hexacosanoylamino-1-O-(alpha-D-galactopyranosyl)nonane-1,3,4-triol
- N-((2S,3S,4R)-3,4-dihydroxy-1-((2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)-tetrahydro-2H-pyran-2-yloxy)nonan-2-yl)hexacosanamide
- N-[(2S,3S,4R)-1-(alpha-D-galactopyranosyloxy)-3,4-dihydroxynonan-2-yl]hexacosanamide
- Definition
- A fatty amide resulting from the formal condensation of the carboxy group of cerotic acid with the amino group of (2S,3S,4R)-2-aminononane-1,3,4-triol and in which the primary hydroxy group of the resulting product has been converted to the corresponding alpha-D-galactopyranoside.
- References
-
- PMID:17419054
- Reaxys:11065900
- Ontology
- ChEBI ( EBI )
- is a type of
-
- has_functional_parent
-
Show first 5 Terms
Phenotype
Phenotype resulting from N-[(2S,3S,4R)-1-(alpha-D-galactopyranosyloxy)-3,4-dihydroxynonan-2-yl]hexacosanamide
Phenotype where environments contain N-[(2S,3S,4R)-1-(alpha-D-galactopyranosyloxy)-3,4-dihydroxynonan-2-yl]hexacosanamide
Phenotype modified by environments containing N-[(2S,3S,4R)-1-(alpha-D-galactopyranosyloxy)-3,4-dihydroxynonan-2-yl]hexacosanamide
Human Disease Model